Related references
Note: Only part of the references are listed.The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis
A. Zeuner et al.
CELL DEATH AND DIFFERENTIATION (2011)
Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
Sama F. Sleiman et al.
JOURNAL OF NEUROSCIENCE (2011)
HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells
Chia-Wei Chou et al.
PLOS ONE (2011)
Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
Luca A. Petruccelli et al.
PLOS ONE (2011)
The role of RAD9 in tumorigenesis
Howard B. Lieberman et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
CD71 (Transferrin Receptor) An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens
Derek K. Marsee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
The role of Sp1 and Sp3 in normal and cancer cell biology
Lin Li et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation
Katrin Friedbichler et al.
BLOOD (2010)
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia
Vanesa Martin et al.
CANCER SCIENCE (2010)
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
Elizabeth A. Griffiths et al.
EPIGENETICS (2010)
Down-regulation of PROS1 Gene Expression by 17β-Estradiol via Estrogen Receptor α (ERα)-Sp1 Interaction Recruiting Receptor-interacting Protein 140 and the Corepressor-HDAC3 Complex
Atsuo Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation
Danny C. W. Yu et al.
MOLECULAR CANCER (2010)
Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line
Jennifer S. Waby et al.
MOLECULAR CANCER (2010)
Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer
Giridhar Mudduluru et al.
MOLECULAR CANCER RESEARCH (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
Maria E. Figueroa et al.
BLOOD (2009)
Development of vorinostat: Current applications and future perspectives for cancer therapy
Victoria M. Richon et al.
CANCER LETTERS (2009)
Epigenetic therapy of leukemia: An update
Nitin Jain et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells
Gabriela Silva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin
Lorena Capparuccia et al.
JOURNAL OF CELL SCIENCE (2009)
Vorinostat in solid and hematologic malignancies
David Siegel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy
Asterios S. Tsiftsoglou et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Hematopoiesis: An evolving paradigm for stem cell biology
Stuart H. Orkin et al.
CELL (2008)
DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients
Patricia Santos Pereira Lima et al.
GENETICS AND MOLECULAR BIOLOGY (2008)
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Andrew J. Wilson et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
DNA methyltransferase and histone deacetylase inhibitors in the treatment of Myelodysplastic syndromes
Elizabeth A. Griffiths et al.
SEMINARS IN HEMATOLOGY (2008)
Epigenetics in acute myeloid leukemia
Christoph Plass et al.
SEMINARS IN ONCOLOGY (2008)
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes
Guillermo Garcia-Manero et al.
BLOOD (2008)
Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia
Yun-Chih Cheng et al.
LEUKEMIA RESEARCH (2007)
v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex
Yahao Bu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression
Yongzhong Wu et al.
GENES TO CELLS (2007)
Brief report: Targeted therapy for inherited GPI deficiency.
Antonio M. Almeida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38α MAPK isoform
Gabriela Silva et al.
JOURNAL OF IMMUNOLOGY (2006)
Gene expression profiles of CD34+ cells in myelodysplastic syndromes:: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
Andrea Pellagatti et al.
BLOOD (2006)
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency
Antonio M. Almeida et al.
NATURE MEDICINE (2006)
Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter
Fabio Stossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
X Agirre et al.
ONCOGENE (2006)
Regulation of histone deacetylase 4 expression by the SP family of transcription factors
F Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma
EC Breen et al.
TUMOR BIOLOGY (2006)
DNA micro-array analysis of myelodysplastic syndrome
H Mano
LEUKEMIA & LYMPHOMA (2006)
Gene expression profiling in the myelodysplastic syndromes
A Pellagatti et al.
HEMATOLOGY (2005)
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
WK Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications
CS Mitsiades et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology
A Pellagatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Sp family of transcription factors is involved in valproic acid-induced expression of Gαi2
IJ Arinze et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin
O Witt et al.
BLOOD (2003)
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
WK Hofmann et al.
BLOOD (2002)
Share Paper
